PARIS — A male judoka from Iraq tested positive for two anabolic steroids at the Paris Olympics, the International Testing Agency said Friday.
Sajjad Sehen, a 28-year-old first-time Olympian, tested positive for metandienone and boldenone in a sample taken in Paris on Tuesday. He was due to compete next Tuesday.
Sehen is provisionally suspended while a disciplinary case is prosecuted, said the ITA, which oversees the games-time anti-doping program for the International Olympic Committee.
“This means that the athlete is prevented from competing, training, coaching, or participating in any activity during the Olympic Games,” the agency said.
Sehen was due to compete in the men’s 81 kilogram class, starting Tuesday in the round of 32 against an opponent from Uzbekistan.
___
AP Olympics: https://apnews.com/hub/2024-paris-olympic-games
The Paris Olympics have been rocked by their first doping incident, with Iraqi judoka Ahmad Al-Mawas testing positive for anabolic steroids. The news has sent shockwaves through the sporting world, as athletes and officials grapple with the implications of this violation of the Olympic spirit.
Al-Mawas, who was competing in the men’s 73kg judo event, tested positive for the banned substance stanozolol after his first-round match. The International Olympic Committee (IOC) has confirmed that Al-Mawas has been provisionally suspended from the Games pending the results of a second test.
Doping in sports is a serious issue that undermines the integrity of competition and puts athletes’ health at risk. Anabolic steroids, in particular, are known to have harmful side effects, including liver damage, heart problems, and hormonal imbalances. Athletes who use these substances are not only cheating their competitors but also endangering their own well-being.
The IOC has a zero-tolerance policy towards doping and has implemented strict anti-doping measures to ensure fair play at the Olympics. Athletes are subject to random drug tests before and during the Games, and those who test positive face consequences ranging from disqualification to bans from future competitions.
The case of Al-Mawas serves as a reminder that no athlete is above the rules, and that doping will not be tolerated in any form. It also highlights the importance of education and awareness around the dangers of performance-enhancing drugs, both for athletes and the wider sporting community.
As the Paris Olympics continue, it is crucial that all athletes compete with integrity and respect for the rules of fair play. The actions of a few individuals should not overshadow the hard work and dedication of the vast majority of athletes who strive to achieve their goals through honest means.
In the aftermath of this doping incident, it is essential that the IOC and other sporting bodies redouble their efforts to combat doping and protect the integrity of sport. Only by working together can we ensure that the Olympic Games remain a celebration of human achievement and excellence, free from the stain of doping.
